Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Exelixis Inc (NQ: EXEL ) 34.51 +0.39 (+1.14%) Streaming Delayed Price Updated: 11:14 AM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Exelixis Inc < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Exelixis (EXEL) Q2 2023 Earnings Call Transcript August 02, 2023 EXEL earnings call for the period ending June 30, 2023. Via The Motley Fool Exelixis Announces Second Quarter 2023 Financial Results and Provides Corporate Update August 01, 2023 From Exelixis, Inc. Via Business Wire Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil July 29, 2023 There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today. Via InvestorPlace 7 Best Cancer Stocks to Invest in Now July 28, 2023 The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now. Via MarketBeat Topics Death Exposures Death 2 Biotech Growth Stocks I'd Buy Right Now July 27, 2023 Both drugmakers seem to have a bright future ahead. Via The Motley Fool 8 Analysts Have This to Say About Exelixis May 10, 2023 Via Benzinga Exelixis (EXEL) Q1 2023 Earnings Call Transcript May 10, 2023 EXEL earnings call for the period ending March 31, 2023. Via The Motley Fool Exelixis: Q1 Earnings Insights May 09, 2023 Via Benzinga Exelixis, Inc. Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Teva Pharmaceuticals Development, Inc. and Teva Pharmaceuticals USA, Inc. July 23, 2023 From Exelixis, Inc. Via Business Wire The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023 July 20, 2023 These are the three bargain biotech stocks showcasing massive upside potential for investors looking to find a position in the sector. Via InvestorPlace Exelixis to Release Second Quarter 2023 Financial Results on Tuesday, August 1, 2023 July 18, 2023 From Exelixis, Inc. Via Business Wire 3 No-Brainer Stocks to Buy With $200 Right Now June 21, 2023 A modest amount of money can go a long way when it's invested in game-changing businesses. Via The Motley Fool Farallon Capital Management Comments on Election of All Three of Its Nominees to Exelixis’ Board May 31, 2023 From Farallon Capital Management L.L.C. Via Business Wire Exelixis to Webcast Fireside Chats as Part of Investor Conferences in June May 30, 2023 From Exelixis, Inc. Via Business Wire The Smartest Stocks to Buy With $20 Right Now and Hold Forever May 29, 2023 These companies can take investors on a lucrative ride, and all for the price of a few lattes. Via The Motley Fool 2 Under-the-Radar Biotech Stocks to Buy in 2023 May 24, 2023 Companies that don't make a lot of noise can still make you a lot of money. Via The Motley Fool 2 Unstoppable Growth Stocks to Buy in 2023 and Beyond May 20, 2023 Both Axsome Therapeutics and Exelixis have potentially game-changing products in their pipelines. Via The Motley Fool Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential May 18, 2023 These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside. Via MarketBeat Exposures Product Safety Nasdaq Bear Market: 5 Exceptional Growth Stocks You'll Regret Not Buying on the Dip May 13, 2023 A sizable dip in the innovation-driven Nasdaq Composite is the perfect excuse for investors to pounce on some phenomenal deals. Via The Motley Fool Exelixis Announces First Quarter 2023 Financial Results and Provides Corporate Update May 09, 2023 From Exelixis, Inc. Via Business Wire Amid Proxy Challenge From Farallon, Exelixis' Board Member Resigns May 08, 2023 Exelixis Inc's (NASDAQ: EXEL) board member Lance Willsey announced his resignation from the Board, Via Benzinga Farallon Capital Management Comments on Successful Campaign for Change at Exelixis May 07, 2023 From Farallon Capital Management L.L.C. Via Business Wire Exelixis Announces Departure of Lance Willsey, M.D. From Board of Directors May 07, 2023 From Exelixis, Inc. Via Business Wire Exelixis to Present at the BofA Securities 2023 Healthcare Conference on May 10, 2023 May 03, 2023 From Exelixis, Inc. Via Business Wire Farallon Capital Urges Exelixis Shareholders to Support Change by Electing Its Three Highly Qualified Director Candidates May 03, 2023 From Farallon Capital Management L.L.C. Via Business Wire Exelixis Files Definitive Proxy Statement and Mails Letter to Shareholders May 01, 2023 From Exelixis, Inc. Via Business Wire Exelixis to Release First Quarter 2023 Financial Results on Tuesday, May 9, 2023 April 25, 2023 From Exelixis, Inc. Via Business Wire The Smartest Stocks to Buy With $20 Right Now and Hold Forever April 22, 2023 These cheap stocks have the potential to skyrocket over the long haul. Via The Motley Fool Nasdaq Bear Market: 5 Sensational Growth Stocks You'll Regret Not Buying on the Dip April 22, 2023 Opportunistic investors would be wise to pounce on innovative growth stocks following a 33% decline in the Nasdaq Composite. Via The Motley Fool Exelixis Advances Board Refreshment Plan April 13, 2023 From Exelixis, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 14 15 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
